Professor Bhaskar Dasgupta is available for video consultations.
+44 (0)20 7616 7693 | firstname.lastname@example.org
Specialties and sub-specialties
Professor Dasgupta was recent Head of Rheumatology and Clinical Director of Research & Audit at Southend University Hospital and holds a Honorary Professorship at Essex University and a Honorary Professorship at Queen Mary’s University, London.
He has had a lifelong interest in Polymyalgia Rheumatica (PMR) and Giant Cell Arteritis (GCA) and has published over 200 original articles on these topics. He was the first in 1990 to report elevated levels of interleukin-6 in these conditions which has opened up the vista of IL-6 blockade such as tocilizumab in GCA, LVV and PMR. He now leads on several new clinical trials of IL-6 blocking and other therapies in PMR and GCA.
Professor Dasgupta was convenor and first author of the BSR guidelines on PMR and GCA in 2009 and is the senior author of the BSR GCA guidelines update published in 2020. Professor Dasgupta was the lead Investigator for the development of EULAR and ACR classification criteria for PMR. This study has also led to validation of patient reported outcome measures for PMR. He has led the EULAR ACR guidelines for PMR and has been member of several EULAR Task forces on Glucocorticoids, GCA core data set and Imaging recommendations.
He has pioneered the fast track pathway for GCA which not only saves sight but also cost - a cost effectiveness analysis done by NHS England showed this pathway to be very cost effective. Southend University Hospital was the recipient of the BSR Outstanding Best Practice Award for developing this pathway that has led to reduction of irreversible sight loss in GCA.
Professor Dasgupta has organised several international symposia and imaging workshops dedicated to PMR GCA large vessel vasculitis. He is a leading international expert in vascular ultrasound as applied to large vessel vasculitis and has been a leading member of EULAR and OMERACT panels that have developed ultrasound definitions and imaging recommendations for large vessel vasculitis. He has developed the BSR online e-learning module for Ultrasound in GCA and Large vessel vasculitis. He has recently described the novel quantitative Halo Score for assessing outcomes in GCA and LVV and is leading the HAS-GCA study on this topic.
National Institute of Clinical Excellence (NICE) approved Tocilizumab for GCA and LVV based on his work with guidelines as to the sub types i.e. Relapsing/refractory patients who are eligible for TCZ. His description of outcomes from Tocilizumab therapy in GCA has drawn the Paul Bacon Vasculitis Award from the British Society for Rheumatology in 2020. He is on the NICE panel adjudicating on the design of clinical trials that are being pursued for the approval in GCA and LVV.
He has helped found the PMRGCAUK, the first national charity dedicated to PMR and GCA and is the Honorary President of the national charity and patron for several regional groups and PMRGCA Scotland.
- Consultant Rheumatologist
Southend University Hospital
- MSK Speciality Lead
North Thames Clinical Research Network
Current teaching posts
- Honorary Professor
University of Essex
- Honorary Professor
Queen Mary University London
Awards and accolades
- Outstanding Best practice Award by British Society for Rheumatology 2016 for Fast track Pathway to reduce sight loss in giant cell arteritis
- JIPMER Puducherry, India (Madras University) 1972 -1979
- All India Institute for Medical Sciences, Delhi,India (for MD General Medicine) 1979 - 1983
- Guy's Hospital Rotation in Rheumatology & GIM 1986 - 1991
Authors: Mackie SL, Dejaco C, Appenzeller S, Camellino D, Duftner C, Gonzalez-Chiappe S, Mahr A, Mukhtyar C, Reynolds G, de Souza AWS, Brouwer E, Bukhari M, Buttgereit F, Byrne D, Cid MC, Cimmino M, Direskeneli H, Gilbert K, Kermani TA, Khan A, Dasgupta B
Published by: Rheumatology, Volume 59, Issue 3, March 2020, Pages 487–494
Authors: Patil P1, Williams M2, Maw WW2, Achilleos K2, Elsideeg S2, Dejaco C3, Borg F2, Gupta S4, Dasgupta B2
Published by: Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-103-6. Epub 2015 May 26
Authors: van der Geest KSM1,2, Borg F2, Kayani A2, Paap D1,3, Gondo P2, Schmidt W4, Luqmani RA5, Dasgupta B6
Published by: Ann Rheum Dis. 2020 Mar;79(3):393-399. doi: 10.1136/annrheumdis-2019-216343. Epub 2020 Jan 3
Bhaskar maintains his internationally renowned career as clinician and researcher with vast musical and cultural interests.
Bhaskar Dasgupta's obsession with music and Indian classical cultural heritage was nurtured by his childhood as depicted by the essay “House without Walls” within his book "Memories of no consequence'. Music has maintained pole position within a wider curiosity for all strands of the Indian cultural heritage; inspired by heroes such as Ashoka, Akbar, Jayadev, Kabir ,Tagore, and Nazrul.
His love of Best of India, Best of Indian has led to several original musical and dance shows staged in London by him and his wife Dalia. These include Kavita K2K, Kahata Kabir, Maatri-Chinta, Kaun Banega Vidyapati, Guldastaa ,Gulbageecha and the forthcoming show juxtaposing Tagore and Nazrul in Sheydiner Dujon. He and his wife, Dalia, hold an open house for established and rising touring musicians and run the charity Chhandam dedicated to unifying the subcontinent's diverse heritage.
Delve into Bhaskar's extensive library of creative endeavours from his professional plays, written and performed on stage. His musical escapades delving deep into Indian classical music, eloquent poetry and intriguing short stories collected in his recent book 'Five notes of the Raga' and latest show in London November 2019 'Rays of Light'.
General enquiries: 020 7935 4444 Appointments: 020 7616 7693 Self-Pay: 020 3219 3315
Your call may be recorded for training and monitoring purposes.